United StatesDoxycycline Hyclate Tablets, USP 100 mg in 500‑count prescription bottles distributed by Acella Pharmaceuticals (NDC 42192-501-05), lot P24ZLK1, exp. 5/31/2027, is being recalled nationwide in the United States (4,680 bottles). The lot failed dissolution specifications during stability testing.
What's being recalled
Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.
Recalling firm: Acella Pharmaceuticals, LLC, Alpharetta, GA, United States.
How to identify it
Lot #: P24ZLK1, Exp 5/31/2027
The hazard
Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)